Related Experiment Video
Updated: Nov 2, 2025

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
Published on: April 9, 2019
Design and validation of an MRI-compatible mechatronic system for needle delivery to localized prostate cancer
Eric Knull1,2, Jeffrey Scott Bax2, Claire Keun Sun Park2,3
1School of Biomedical Engineering, Faculty of Engineering, Western University, London, Ontario, Canada.
Purpose:
Prostate cancer is the most common non-cutaneous cancer among men in the United States and is the second leading cause of cancer death in American men. (Siegel et al. [2019] CA: A Cancer J Clin.69(1):7-34.) Focal laser ablation (FLA) has the potential to control small tumors while preserving urinary and erectile function by leaving the neurovascular bundles and urethral sphincters intact. Accurate needle guidance is critical to the success of FLA. Multiparametric magnetic resonance images (mpMRI) can be used to identify targets, guide needles, and assess treatment outcomes. The purpose of this work was to design and evaluate the accuracy of an MR-compatible mechatronic system for in-bore transperineal guidance of FLA ablation needles to localized lesions in the prostate.
Methods:
The mechatronic system was constructed entirely of non-ferromagnetic materials, with actuation controlled by piezoelectric motors and optical encoders. The needle guide hangs between independent front and rear two-link arms, which allows for horizontal and vertical translation as well as pitch and yaw rotation of the guide with a 6.0 cm range of motion in each direction. Needles are inserted manually through a chosen hole in the guide, which has been aligned with the target in the prostate. Open-air positioning error was evaluated using an optical tracking system (0.25 mm RMS accuracy) to measure 125 trajectories in free space. Correction of systematic bias in the system was performed using 85 of the trajectories, and the remaining 40 were used to estimate the residual error. The error was calculated as the horizontal and vertical displacement between the axis of the desired and measured trajectories at a typical needle insertion depth of 10 cm. MR-compatibility was evaluated using a grid phantom to assess image degradation due to the presence of the system, and induced force, heating, and electrical interference in the system were assessed qualitatively. In-bore positioning error was evaluated on 25 trajectories.
Results:
Open-air mean positioning error at the needle tip was 0.80 ± 0.36 mm with a one-sided 95% confidence interval of 1.40 mm. The mean deviation of needle trajectories from the planned direction was 0.14 ± 0.06∘ . In the MR bore, the mean positioning error at the needle tip was 2.11 ± 1.05 mm with a one-sided 95% prediction interval of 3.84 mm. The mean angular error was 0.49 ± 0.26∘ . The system was found to be compatible with the MR environment under the specified gradient-echo sequence parameters used in this study.
Conclusion:
A complete system for delivering needles to localized prostate tumors was developed and described in this work, and its compatibility with the MR environment was demonstrated. In-bore MRI positioning error was sufficiently small for targeting small localized prostate tumors.
Insights
A new MR-compatible system accurately guides needles for prostate cancer focal laser ablation. This technology shows promise for precise tumor targeting while preserving patient function.
Area of Science:
- Medical Engineering
- Oncology
- Robotics
Background:
- Prostate cancer is a leading cause of cancer death in men.
- Focal laser ablation (FLA) offers a way to treat small tumors while preserving function.
- Accurate needle guidance is essential for successful FLA.
Purpose of the Study:
- To design and evaluate an MR-compatible mechatronic system for transperineal needle guidance.
- To achieve accurate targeting of localized prostate lesions for FLA.
Main Methods:
- Developed a non-ferromagnetic mechatronic system with piezoelectric motors and optical encoders.
- Evaluated open-air positioning accuracy using an optical tracking system.
- Assessed MR-compatibility, including image degradation, force, heating, and electrical interference.
- Measured in-bore positioning error for transperineal needle guidance.
Main Results:
- Open-air mean positioning error was 0.80 ± 0.36 mm.
- Mean angular deviation in open air was 0.14 ± 0.06°.
- In-bore mean positioning error was 2.11 ± 1.05 mm, with a 95% prediction interval of 3.84 mm.
- The system demonstrated compatibility with the MR environment.
Conclusions:
- A complete MR-compatible system for needle delivery in prostate cancer treatment was developed.
- The system's in-bore MRI positioning accuracy is suitable for targeting small prostate tumors.
- This technology supports precise FLA of localized prostate cancer.

